DCGI gives approval for Bharat Biotech's Covaxin for children aged 6-12 - Daily News Indiatimes.com: Trending stories, Latest News, Breaking News, National News, World News

Daily News Indiatimes.com: Trending stories, Latest News, Breaking News, National News, World News

Indiatimes.com brings you the news, articles, stories and videos on entertainment, latest lifestyle, culture & new technologies emerging worldwide.Read the Latest News On Business, Politics, Sports, Entertainment & Much More From India And Around The World At. Comprehensive, up-to-date news coverage, aggregated from sources all over the world by Google News.

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Tuesday, April 26, 2022

DCGI gives approval for Bharat Biotech's Covaxin for children aged 6-12

The Drug Controller General of India (DCGI) has given a restricted emergency use approval for Bharat Biotech's Covid-19 vaccine, Covaxin, for children between the age of six and 12. A Subject Expert Committee (SEC) of the DCGI had last week asked Bharat Biotech for additional data on Covaxin, for administering it to children aged below 12.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/6zqS8oD

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages